Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 May 1;2(3):213-222.
doi: 10.2217/dmt.12.21.

β-cell preservation and regeneration for diabetes treatment: where are we now?

Michael J Karadimos  1 , Archana Kapoor, Ilham El Khattabi, Arun Sharma
Affiliations

β-cell preservation and regeneration for diabetes treatment: where are we now?

Michael J Karadimos et al. Diabetes Manag (Lond). .

Abstract

Over the last decade, our knowledge of β-cell biology has expanded with the use of new scientific techniques and strategies. Growth factors, hormones and small molecules have been shown to enhance β-cell proliferation and function. Stem cell technology and research into the developmental biology of the pancreas have yielded new methods for in vivo and in vitro regeneration of β cells from stem cells and endogenous progenitors as well as transdifferentiation of non-β cells. Novel pharmacological approaches have been developed to preserve and enhance β-cell function. Strategies to increase expression of insulin gene transcription factors in dysfunctional and immature β cells have ameliorated these impairments. Hence, we suggest that strategies to minimize β-cell loss and to increase their function and regeneration will ultimately lead to therapy for both Type 1 and 2 diabetes.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Research and Clinical Practice. 2010;87(1):4–14. [Insightful review on the prevalence of diabetes worldwide.] - PubMed
    1. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes. Diabetes Care. 2004;27(5):1047–1053. - PubMed
    1. Weir GC, Marselli L, Marchetti P, Katsuta H, Jung MH, Bonner-Weir S. Towards better understanding of the contributions of overwork and glucotoxicity to the β-cell inadequacy of Type 2 diabetes. Diabetes Obes. Metab. 2009;11:82–90. [Excellent review on the contribution of β-cell dysfunction to Type 2 diabetes.] - PubMed
    1. Gianani R, Eisenbarth GS. The stages of Type 1A diabetes: 2005. Immunol. Rev. 2005;204(1):232–249. - PubMed
    1. Rahier J, Guiot Y, Goebbels RM, Sempoux C, Henquin JC. Pancreatic β-cell mass in European subjects with Type 2 diabetes. Diabetes Obes. Metab. 2008;10:32–42. - PubMed

LinkOut - more resources